Sepsis-Associated Encephalopathy

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Sepsis-Associated Encephalopathy trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT04230447

Establishment of a Cohort of Patients With Sepsis-associated Encephalopathy (SAE)

In this study, the researcher involved the sepsis patients(defined by sepsis 3.0) in Peking Union Medical College Hospital. The SAE was defined as the Glasgow C…

China3,000 participantsStarted 2021-02-01

Treatment: No intervention

All recent trials (19 shown)

TerminatedNot Applicable

NCT05307003

Trazodone vs. Quetiapine for the Treatment of ICU Delirium

This is a single-center, prospective observational pilot study. The objective of this study is to evaluate the effectiveness of trazodone as compared to quetiap…

United States10 participantsStarted 2024-06-01

Treatment: Trazodone, Quetiapine

Active — Not RecruitingNot Applicable

NCT03133208

Sepsis Associated Encephalopathy (SAE) Biomarkers

Sepsis associated encephalopathy (SAE) is a poorly understood acute cerebral dysfunction that frequently appears in the setting of sepsis induced systemic infla…

United States90 participantsStarted 2017-06-01

Treatment: Blood draws

Sepsis-Associated Encephalopathy

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Establishment of a Cohort of Patients With Sepsis-associated Encephalopathy (SAE)

All recent trials (19 shown)

Trazodone vs. Quetiapine for the Treatment of ICU Delirium

Sepsis Associated Encephalopathy (SAE) Biomarkers

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Establishment of a Cohort of Patients With Sepsis-associated Encephalopathy (SAE)

All recent trials (19 shown)

Trazodone vs. Quetiapine for the Treatment of ICU Delirium

Sepsis Associated Encephalopathy (SAE) Biomarkers

Ulinastatin Treatment Reduces the Incidence of Sepsis-associated Encephalopathy

Optic Nerve Sheath Diameter / Eyeball Transverse Diameter Ratio and Prognosis of Sepsis Associated Encephalopathy

Optic Nerve Sheath Diameter for Prediction of Sepsis Associated Encephalopathy

Role of MSCT Volumetry in Assessment of Brain Atrophy in Septic Patients

Adjunctive Sedation With Dexmedetomidine for the Prevention of Severe Inflammation and Septic Encephalopathy

Neurocognitive Impairment in Pediatric Patients With Meningoencephalitis and Sepsis-associated Encephalopathy

Correlation of Formyl Peptide Receptor 1 With Sepsis-related Encephalopathy

The Dynamic Change of MMN in Patients With Sepsis Associated Encephalopathy

Hemodynamic Optimisation Guided With Transcranial Doppler in Septic Shock

Cognitive Processing in Patients Surviving Delirium. Neuropsychological, EEG and Structural Brain Correlates.

Cerebral Oxygen Challenge of Passive Leg Raising Test in Sepsis

Relationship of Cerebral Perfusion Pressure Variability to Sepsis-associated Encephalopathy

Prospective Analysis of Septic Associated Encephalopathy Using the Non-invasive Acoustocerebrography-ACG

Neurological Outcome in Surgical and Non-surgical Septic Patients

Septic Encephalopathy and Late Cognitive Dysfunction

Pathogenesis and Cerebrovascular Manifestations of Septic Encephalopathy